Skip to main content

Table 1 Characteristics and description of the study population

From: Non-adherence to community oral-antibiotic treatment in children with fast-breathing pneumonia in Malawi– secondary analysis of a prospective cohort study

N = 834

 

N (%)

Age

2–11 months

268 (32.1%)

12–23 months

273 (32.7%)

24–59 months

293 (35.1%)

Gender

Female

429 (51.4%)

Male

391 (46.9%)

Missing

14 (1.7%)

District

Kabudula

479 (57.4%)

Mchinji

355 (42.6%)

Clinical malaria diagnosis

Yes

345 (41.4%)

No

489 (58.6%)

Diarrhoea diagnosis

Yes

28 (3.4%)

No

806 (96.6%)

Any concurrent diagnosisa

Yes

423 (50.7%)

No

411 (49.3%)

Prescribed LAb

Yes

430 (51.6%)

No

404 (48.4%)

Prescribed paracetamol

Yes

430 (51.6%)

No

404 (48.4%)

Prescribed multiple drugs

Yes

515 (38.2%)

No

319 (38.3%)

Duration of illness before diagnosis

<24 h

482 (58.1%)

>24 h

347 (41.9%)

Vomited after taking antibiotics

Yes

726 (12.7%)

No

106 (87.3%)

 

Number

Medianc (range)

Respiratory rate (breaths/min)

Age 2–11 mths

253

55 (40–83)

Age 12–59 mths

545

46 (40–100)

Temperature (°C)

803

42.0 (34.3–42)

Oxygen Saturation (%)

826

97 (90–100)

 

Number

Meanc (SD)

Heart rate (beats/min)

Age 2–11 mths

260

136 (24.7)

Age 12–23 mths

260

138 (24.9)

Age 24–59 mths

279

129 (23.2)

  1. LA lumefantrine artemether, SD standard deviation
  2. aDiagnoses included: malaria, diarrhoea, ear infection, rash and other specified
  3. bThe child was presumptively prescribed the anti-malaria Lumefantrine Artemether (LA) by the community health worker
  4. cMedian used for skewed data, mean for normally distributed data